世界の脂肪肝治療市場規模・現状・予測2021-2027

【英語タイトル】Global Fatty Liver Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR2324)・商品コード:QY21APR2324
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:97
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、脂肪肝治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン)、用途別市場規模(病院・クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・脂肪肝治療の市場動向
・企業の競争状況、市場シェア
・脂肪肝治療の種類別市場規模(チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン)
・脂肪肝治療の用途別市場規模(病院・クリニック、その他)
・脂肪肝治療の北米市場規模2016-2027(アメリカ、カナダ)
・脂肪肝治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・脂肪肝治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・脂肪肝治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・脂肪肝治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Cardax、Daewoong、Roche、Glenmark、GW、Limerick BioPharma、Merck、Novartis、Orchid、AstraZeneca)
・結論
【レポートの概要】

Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.
The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others.

Market Analysis and Insights: Global Fatty Liver Treatment Market
The global Fatty Liver Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fatty Liver Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fatty Liver Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fatty Liver Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fatty Liver Treatment market.

Global Fatty Liver Treatment Scope and Market Size
Fatty Liver Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fatty Liver Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Thiazolidinedione
Vitamin E
Metformin Statins
Polyunsaturated Fatty Acids
Angiotensin Receptor Blockers
Pentoxifylline

Segment by Application
Hospitals and Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Liver Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Thiazolidinedione
1.2.3 Vitamin E
1.2.4 Metformin Statins
1.2.5 Polyunsaturated Fatty Acids
1.2.6 Angiotensin Receptor Blockers
1.2.7 Pentoxifylline
1.3 Market by Application
1.3.1 Global Fatty Liver Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Fatty Liver Treatment Market Perspective (2016-2027)
2.2 Fatty Liver Treatment Growth Trends by Regions
2.2.1 Fatty Liver Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fatty Liver Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Fatty Liver Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Fatty Liver Treatment Industry Dynamic
2.3.1 Fatty Liver Treatment Market Trends
2.3.2 Fatty Liver Treatment Market Drivers
2.3.3 Fatty Liver Treatment Market Challenges
2.3.4 Fatty Liver Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Fatty Liver Treatment Players by Revenue
3.1.1 Global Top Fatty Liver Treatment Players by Revenue (2016-2021)
3.1.2 Global Fatty Liver Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Fatty Liver Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fatty Liver Treatment Revenue
3.4 Global Fatty Liver Treatment Market Concentration Ratio
3.4.1 Global Fatty Liver Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Treatment Revenue in 2020
3.5 Fatty Liver Treatment Key Players Head office and Area Served
3.6 Key Players Fatty Liver Treatment Product Solution and Service
3.7 Date of Enter into Fatty Liver Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Fatty Liver Treatment Breakdown Data by Type
4.1 Global Fatty Liver Treatment Historic Market Size by Type (2016-2021)
4.2 Global Fatty Liver Treatment Forecasted Market Size by Type (2022-2027)

5 Fatty Liver Treatment Breakdown Data by Application
5.1 Global Fatty Liver Treatment Historic Market Size by Application (2016-2021)
5.2 Global Fatty Liver Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Fatty Liver Treatment Market Size (2016-2027)
6.2 North America Fatty Liver Treatment Market Size by Type
6.2.1 North America Fatty Liver Treatment Market Size by Type (2016-2021)
6.2.2 North America Fatty Liver Treatment Market Size by Type (2022-2027)
6.2.3 North America Fatty Liver Treatment Market Size by Type (2016-2027)
6.3 North America Fatty Liver Treatment Market Size by Application
6.3.1 North America Fatty Liver Treatment Market Size by Application (2016-2021)
6.3.2 North America Fatty Liver Treatment Market Size by Application (2022-2027)
6.3.3 North America Fatty Liver Treatment Market Size by Application (2016-2027)
6.4 North America Fatty Liver Treatment Market Size by Country
6.4.1 North America Fatty Liver Treatment Market Size by Country (2016-2021)
6.4.2 North America Fatty Liver Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Fatty Liver Treatment Market Size (2016-2027)
7.2 Europe Fatty Liver Treatment Market Size by Type
7.2.1 Europe Fatty Liver Treatment Market Size by Type (2016-2021)
7.2.2 Europe Fatty Liver Treatment Market Size by Type (2022-2027)
7.2.3 Europe Fatty Liver Treatment Market Size by Type (2016-2027)
7.3 Europe Fatty Liver Treatment Market Size by Application
7.3.1 Europe Fatty Liver Treatment Market Size by Application (2016-2021)
7.3.2 Europe Fatty Liver Treatment Market Size by Application (2022-2027)
7.3.3 Europe Fatty Liver Treatment Market Size by Application (2016-2027)
7.4 Europe Fatty Liver Treatment Market Size by Country
7.4.1 Europe Fatty Liver Treatment Market Size by Country (2016-2021)
7.4.2 Europe Fatty Liver Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Fatty Liver Treatment Market Size (2016-2027)
8.2 Asia-Pacific Fatty Liver Treatment Market Size by Type
8.2.1 Asia-Pacific Fatty Liver Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fatty Liver Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fatty Liver Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Fatty Liver Treatment Market Size by Application
8.3.1 Asia-Pacific Fatty Liver Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fatty Liver Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fatty Liver Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Fatty Liver Treatment Market Size by Region
8.4.1 Asia-Pacific Fatty Liver Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fatty Liver Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Fatty Liver Treatment Market Size (2016-2027)
9.2 Latin America Fatty Liver Treatment Market Size by Type
9.2.1 Latin America Fatty Liver Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Fatty Liver Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Fatty Liver Treatment Market Size by Type (2016-2027)
9.3 Latin America Fatty Liver Treatment Market Size by Application
9.3.1 Latin America Fatty Liver Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Fatty Liver Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Fatty Liver Treatment Market Size by Application (2016-2027)
9.4 Latin America Fatty Liver Treatment Market Size by Country
9.4.1 Latin America Fatty Liver Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Fatty Liver Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Fatty Liver Treatment Market Size (2016-2027)
10.2 Middle East & Africa Fatty Liver Treatment Market Size by Type
10.2.1 Middle East & Africa Fatty Liver Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fatty Liver Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fatty Liver Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Fatty Liver Treatment Market Size by Application
10.3.1 Middle East & Africa Fatty Liver Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fatty Liver Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fatty Liver Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Fatty Liver Treatment Market Size by Country
10.4.1 Middle East & Africa Fatty Liver Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fatty Liver Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cardax
11.1.1 Cardax Company Details
11.1.2 Cardax Business Overview
11.1.3 Cardax Fatty Liver Treatment Introduction
11.1.4 Cardax Revenue in Fatty Liver Treatment Business (2016-2021)
11.1.5 Cardax Recent Development
11.2 Daewoong
11.2.1 Daewoong Company Details
11.2.2 Daewoong Business Overview
11.2.3 Daewoong Fatty Liver Treatment Introduction
11.2.4 Daewoong Revenue in Fatty Liver Treatment Business (2016-2021)
11.2.5 Daewoong Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Fatty Liver Treatment Introduction
11.3.4 Roche Revenue in Fatty Liver Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Glenmark
11.4.1 Glenmark Company Details
11.4.2 Glenmark Business Overview
11.4.3 Glenmark Fatty Liver Treatment Introduction
11.4.4 Glenmark Revenue in Fatty Liver Treatment Business (2016-2021)
11.4.5 Glenmark Recent Development
11.5 GW
11.5.1 GW Company Details
11.5.2 GW Business Overview
11.5.3 GW Fatty Liver Treatment Introduction
11.5.4 GW Revenue in Fatty Liver Treatment Business (2016-2021)
11.5.5 GW Recent Development
11.6 Limerick BioPharma
11.6.1 Limerick BioPharma Company Details
11.6.2 Limerick BioPharma Business Overview
11.6.3 Limerick BioPharma Fatty Liver Treatment Introduction
11.6.4 Limerick BioPharma Revenue in Fatty Liver Treatment Business (2016-2021)
11.6.5 Limerick BioPharma Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Fatty Liver Treatment Introduction
11.7.4 Merck Revenue in Fatty Liver Treatment Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Fatty Liver Treatment Introduction
11.8.4 Novartis Revenue in Fatty Liver Treatment Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Orchid
11.9.1 Orchid Company Details
11.9.2 Orchid Business Overview
11.9.3 Orchid Fatty Liver Treatment Introduction
11.9.4 Orchid Revenue in Fatty Liver Treatment Business (2016-2021)
11.9.5 Orchid Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Fatty Liver Treatment Introduction
11.10.4 AstraZeneca Revenue in Fatty Liver Treatment Business (2016-2021)
11.10.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fatty Liver Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Thiazolidinedione
Table 3. Key Players of Vitamin E
Table 4. Key Players of Metformin Statins
Table 5. Key Players of Polyunsaturated Fatty Acids
Table 6. Key Players of Angiotensin Receptor Blockers
Table 7. Key Players of Pentoxifylline
Table 8. Global Fatty Liver Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Fatty Liver Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Fatty Liver Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Fatty Liver Treatment Market Share by Regions (2016-2021)
Table 12. Global Fatty Liver Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Fatty Liver Treatment Market Share by Regions (2022-2027)
Table 14. Fatty Liver Treatment Market Trends
Table 15. Fatty Liver Treatment Market Drivers
Table 16. Fatty Liver Treatment Market Challenges
Table 17. Fatty Liver Treatment Market Restraints
Table 18. Global Fatty Liver Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Fatty Liver Treatment Market Share by Players (2016-2021)
Table 20. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fatty Liver Treatment as of 2020)
Table 21. Ranking of Global Top Fatty Liver Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Fatty Liver Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Fatty Liver Treatment Product Solution and Service
Table 25. Date of Enter into Fatty Liver Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Fatty Liver Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Fatty Liver Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Fatty Liver Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Fatty Liver Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Fatty Liver Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Fatty Liver Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Fatty Liver Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Fatty Liver Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Fatty Liver Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Fatty Liver Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Fatty Liver Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Fatty Liver Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Fatty Liver Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Fatty Liver Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Fatty Liver Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Fatty Liver Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Fatty Liver Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Fatty Liver Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Fatty Liver Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Fatty Liver Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fatty Liver Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Fatty Liver Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Fatty Liver Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Fatty Liver Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Fatty Liver Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Fatty Liver Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Fatty Liver Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Fatty Liver Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Fatty Liver Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Fatty Liver Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Fatty Liver Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Fatty Liver Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fatty Liver Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Fatty Liver Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Fatty Liver Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Fatty Liver Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Fatty Liver Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Fatty Liver Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Cardax Company Details
Table 66. Cardax Business Overview
Table 67. Cardax Fatty Liver Treatment Product
Table 68. Cardax Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 69. Cardax Recent Development
Table 70. Daewoong Company Details
Table 71. Daewoong Business Overview
Table 72. Daewoong Fatty Liver Treatment Product
Table 73. Daewoong Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 74. Daewoong Recent Development
Table 75. Roche Company Details
Table 76. Roche Business Overview
Table 77. Roche Fatty Liver Treatment Product
Table 78. Roche Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 79. Roche Recent Development
Table 80. Glenmark Company Details
Table 81. Glenmark Business Overview
Table 82. Glenmark Fatty Liver Treatment Product
Table 83. Glenmark Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 84. Glenmark Recent Development
Table 85. GW Company Details
Table 86. GW Business Overview
Table 87. GW Fatty Liver Treatment Product
Table 88. GW Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 89. GW Recent Development
Table 90. Limerick BioPharma Company Details
Table 91. Limerick BioPharma Business Overview
Table 92. Limerick BioPharma Fatty Liver Treatment Product
Table 93. Limerick BioPharma Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 94. Limerick BioPharma Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Fatty Liver Treatment Product
Table 98. Merck Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Novartis Company Details
Table 101. Novartis Business Overview
Table 102. Novartis Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 103. Novartis Recent Development
Table 104. Orchid Company Details
Table 105. Orchid Business Overview
Table 106. Orchid Fatty Liver Treatment Product
Table 107. Orchid Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 108. Orchid Recent Development
Table 109. AstraZeneca Company Details
Table 110. AstraZeneca Business Overview
Table 111. AstraZeneca Fatty Liver Treatment Product
Table 112. AstraZeneca Revenue in Fatty Liver Treatment Business (2016-2021) & (US$ Million)
Table 113. AstraZeneca Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Liver Treatment Market Share by Type: 2020 VS 2027
Figure 2. Thiazolidinedione Features
Figure 3. Vitamin E Features
Figure 4. Metformin Statins Features
Figure 5. Polyunsaturated Fatty Acids Features
Figure 6. Angiotensin Receptor Blockers Features
Figure 7. Pentoxifylline Features
Figure 8. Global Fatty Liver Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Fatty Liver Treatment Report Years Considered
Figure 12. Global Fatty Liver Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Fatty Liver Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Fatty Liver Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Fatty Liver Treatment Market Share by Regions (2022-2027)
Figure 16. Global Fatty Liver Treatment Market Share by Players in 2020
Figure 17. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fatty Liver Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Fatty Liver Treatment Revenue in 2020
Figure 19. Global Fatty Liver Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Fatty Liver Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Fatty Liver Treatment Market Share by Type (2016-2027)
Figure 23. North America Fatty Liver Treatment Market Share by Application (2016-2027)
Figure 24. North America Fatty Liver Treatment Market Share by Country (2016-2027)
Figure 25. United States Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Fatty Liver Treatment Market Share by Type (2016-2027)
Figure 29. Europe Fatty Liver Treatment Market Share by Application (2016-2027)
Figure 30. Europe Fatty Liver Treatment Market Share by Country (2016-2027)
Figure 31. Germany Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Fatty Liver Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Fatty Liver Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Fatty Liver Treatment Market Share by Region (2016-2027)
Figure 41. China Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Fatty Liver Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Fatty Liver Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Fatty Liver Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Fatty Liver Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Fatty Liver Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Fatty Liver Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Fatty Liver Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Cardax Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 61. Daewoong Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 63. Glenmark Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 64. GW Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 65. Limerick BioPharma Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 68. Orchid Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Fatty Liver Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【掲載企業】

Cardax、Daewoong、Roche、Glenmark、GW、Limerick BioPharma、Merck、Novartis、Orchid、AstraZeneca

★調査レポート[世界の脂肪肝治療市場規模・現状・予測2021-2027] (コード:QY21APR2324)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の脂肪肝治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆